It would be of interest to investigate the time course (early versus late onset) of the expression of different NOS isoforms and VEGF after MRSA pneumonia and sepsis, and to evaluate the role of specific NOS inhibitors on MRSA sepsis-induced vascular hyperpermeability. This evidence concerns the gene NOS1 and Methicillin-Resistant Staphylococcus Aureus Pneumonia.